Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation-Reference-Cited by-同舟云学术

Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation

Published:2015-05-26 Issue:8 Volume:3 Page:855-863
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Van Allen Eliezer M.,Golay Hadrien G.,Liu Yan,Koyama Shohei,Wong Karrie,Taylor-Weiner Amaro,Giannakis Marios,Harden Maegan,Rojas-Rudilla Vanesa,Chevalier Aaron,Thai Tran,Lydon Christine,Mach Stacy,Avila Ada G.,Wong Joshua A.,Rabin Alexandra R.,Helmkamp Joshua,Sholl Lynette,Carter Scott L.,Oxnard Geoffrey,Janne Pasi,Getz Gad,Lindeman Neal,Hammerman Peter S.,Garraway Levi A.,Hodi F. Stephen,Rodig Scott J.,Dranoff Glenn,Wong Kwok-Kin,Barbie David A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating the PD-L1 Prognostic Biomarker in Non-Muscle Invasive Bladder Cancer in Clinical Practice—A Comprehensive Review on State-of-the-Art Advances and Critical Issues;Journal of Clinical Medicine;2024-04-10

2. Emerging Prognostic and Predictive Factors in Pancreatic Cancer;Modern Pathology;2023-11

3. PTPRD/PTPRT mutation correlates to treatment outcomes of immunotherapy and immune landscape in pan-cancers;CHINESE J CANCER RES;2023

4. Renal Sarcoidosis-like Reaction Induced by PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer: A Case Report and Literature Review;Medicina;2023-05-21

5. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes;Computers in Biology and Medicine;2022-09